Search

Your search keyword '"Lingvay, Ildiko"' showing total 896 results

Search Constraints

Start Over You searched for: Author "Lingvay, Ildiko" Remove constraint Author: "Lingvay, Ildiko"
896 results on '"Lingvay, Ildiko"'

Search Results

4. Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial

6. The Effect of Semaglutide on Mortality and COVID-19–Related Deaths: An Analysis From the SELECT Trial

7. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

9. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

20. Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) – Diabetes: rationale and design

21. LBP-032 Semaglutide improves cardiovascular outcomes in patients with high risk for metabolic dysfunction-associated steatohepatitis-a subgroup analysis from the SELECT trial

24. Baseline risk markers and visit-to-visit variability in relation to kidney outcomes – A post-hoc analysis of the PERL study

27. Hyposialylated IgG activates endothelial IgG receptor FcγRIIB to promote obesity-induced insulin resistance

28. Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

29. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

30. #2496 Effect of semaglutide on kidney outcomes in people with overweight or obesity and established cardiovascular disease in the SELECT trial

33. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

35. Insulin Sensitivity After Living Donor Nephrectomy

38. Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT.

39. Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.

40. Approach to weight management in patients with advanced chronic kidney disease in a real‐life clinical setting.

48. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

50. Managing Obesity in Heart Failure

Catalog

Books, media, physical & digital resources